Last 12 months
Inside the activity.
0 purchase rows · 52 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 13 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 14 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC |
CRITCHFIELD GREGORY CDirector
|
GrantStock Option (right to buy) · Derivative | 10,549 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001534969-24-000136 · wk-form4_1717792347.xml · derivative · entry 2 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,549 Underlying: Class A Common Stock · 10,549 shares Expires 2034-06-06 F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC |
CRITCHFIELD GREGORY CDirector
|
GrantClass A Common Stock | 7,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000136 · wk-form4_1717792347.xml · nonDerivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 807,270 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC |
Lawrence Sandra AJDirector
|
GrantStock Option (right to buy) · Derivative | 10,549 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001534969-24-000134 · wk-form4_1717792323.xml · derivative · entry 2 Lawrence Sandra AJ · CIK 0001306386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,549 Underlying: Class A Common Stock · 10,549 shares Expires 2034-06-06 F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC |
Lawrence Sandra AJDirector
|
GrantClass A Common Stock | 7,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000134 · wk-form4_1717792323.xml · nonDerivative · entry 1 Lawrence Sandra AJ · CIK 0001306386 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,117 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC |
Trimble RyanDirector
|
GrantStock Option (right to buy) · Derivative | 10,549 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001534969-24-000135 · wk-form4_1717792336.xml · derivative · entry 2 Trimble Ryan · CIK 0001871513 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,549 Underlying: Class A Common Stock · 10,549 shares Expires 2034-06-06 F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC |
Trimble RyanDirector
|
GrantClass A Common Stock | 7,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000135 · wk-form4_1717792336.xml · nonDerivative · entry 1 Trimble Ryan · CIK 0001871513 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,117 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC |
Kamdar Kim P.Director
|
GrantStock Option (right to buy) · Derivative | 10,549 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001534969-24-000133 · wk-form4_1717792311.xml · derivative · entry 2 Kamdar Kim P. · CIK 0001535065 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,549 Underlying: Class A Common Stock · 10,549 shares Expires 2034-06-06 F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:32 UTC |
Kamdar Kim P.Director
|
GrantClass A Common Stock | 7,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000133 · wk-form4_1717792311.xml · nonDerivative · entry 1 Kamdar Kim P. · CIK 0001535065 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,746 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:31 UTC |
Mirza Mansoor RazaDirector
|
GrantStock Option (right to buy) · Derivative | 10,549 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001534969-24-000132 · wk-form4_1717792300.xml · derivative · entry 2 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,549 Underlying: Class A Common Stock · 10,549 shares Expires 2034-06-06 F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:31 UTC |
Mirza Mansoor RazaDirector
|
GrantClass A Common Stock | 7,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000132 · wk-form4_1717792300.xml · nonDerivative · entry 1 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,117 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:31 UTC |
Barlow Jane FDirector
|
GrantStock Option (right to buy) · Derivative | 10,549 | $0.00 Strike: $8.43 | $0.00 |
DisclosureSEC source: 0001534969-24-000131 · wk-form4_1717792288.xml · derivative · entry 2 Barlow Jane F · CIK 0001736026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,549 Underlying: Class A Common Stock · 10,549 shares Expires 2034-06-06 F2 · derivative.exercise_date: Consists of stock options granted pursuant to Sera Prognostics, Inc.'s Non-Employee Director Compensation Policy and its 2021 Equity Incentive Plan. These stock options vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 20:31 UTC |
Barlow Jane FDirector
|
GrantClass A Common Stock | 7,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000131 · wk-form4_1717792288.xml · nonDerivative · entry 1 Barlow Jane F · CIK 0001736026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,117 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over one year as follows: 1/12 of the original grant amount vests in monthly installments for one year following the vesting commencement date, which is June 6, 2024, subject to the reporting person continuing to provide services to the issuer. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
Phillips JoshuaDirector
|
OtherClass A Common Stock | 36,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 7 Phillips Joshua · CIK 0001871555 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Catalyst Health Ventures Follow-on Fund, L.P. Disclosed balance after: 8 F9 · kind: CHV FO distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · ownership.nature: CHV GP LLC is the general partner of CHV LP and Catalyst Health Ventures (PF), L.P. ("CHV PF"). CHV I GP LLC (formerly known as "CHV III GP LLC") is the general partner of CHV Investments LLC ("CHV Investments") and Catalyst Health Ventures Follow-on Fund, L.P. ("CHV FO", together with CHV LP, CHV PF and CHV Investments, the "CHV Funds"). Joshua Phillips, a member of the Issuer's board of directors, is a managing member of CHV GP LLC and CHV I GP LLC, and a limited partner of CHV PF, CHV Investments, CHV GP LLC, and CHV I GP LLC. The securities held by the CHV Funds may be deemed to be beneficially owned by Joshua Phillips. Joshua Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
Phillips JoshuaDirector
|
OtherClass A Common Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 6 Phillips Joshua · CIK 0001871555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,292 F7 · kind: Represents the pro-rata distribution from CHV Investments, and not a purchase or sale, without additional consideration. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
Phillips JoshuaDirector
|
OtherClass A Common Stock | 2,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 5 Phillips Joshua · CIK 0001871555 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 2,297 F7 · kind: Represents the pro-rata distribution from CHV Investments, and not a purchase or sale, without additional consideration. F8 · ownership.nature: The shares are held by a living trust, of which the reporting person is a trustee and in which the reporting person has a beneficial interest. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
Phillips JoshuaDirector
|
OtherClass A Common Stock | 356,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 4 Phillips Joshua · CIK 0001871555 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by CHV Investments, LLC Disclosed balance after: 17,684 F6 · kind: CHV Investments distributed these shares to its limited members on a pro rata basis, for no consideration. F2 · ownership.nature: CHV GP LLC is the general partner of CHV LP and Catalyst Health Ventures (PF), L.P. ("CHV PF"). CHV I GP LLC (formerly known as "CHV III GP LLC") is the general partner of CHV Investments LLC ("CHV Investments") and Catalyst Health Ventures Follow-on Fund, L.P. ("CHV FO", together with CHV LP, CHV PF and CHV Investments, the "CHV Funds"). Joshua Phillips, a member of the Issuer's board of directors, is a managing member of CHV GP LLC and CHV I GP LLC, and a limited partner of CHV PF, CHV Investments, CHV GP LLC, and CHV I GP LLC. The securities held by the CHV Funds may be deemed to be beneficially owned by Joshua Phillips. Joshua Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
Phillips JoshuaDirector
|
OtherClass A Common Stock | 1,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 3 Phillips Joshua · CIK 0001871555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,258 F4 · kind: Represents the pro-rata distribution from CHV PF, and not a purchase or sale, without additional consideration. F5 · balance_after: Includes 25,815 shares received as a pro-rata distribution from CHV LP and 1,970 shares received as a pro-rata distribution from CHV PF. In prior reports, the reporting person reported beneficial ownership of 388,622 shares held directly by CHV LP and 166,098 shares held directly by CHV PF. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
Phillips JoshuaDirector
|
OtherClass A Common Stock | 156,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 2 Phillips Joshua · CIK 0001871555 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Catalyst Health Ventures (PF), L.P. Disclosed balance after: 9,766 F3 · kind: CHV PF distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · ownership.nature: CHV GP LLC is the general partner of CHV LP and Catalyst Health Ventures (PF), L.P. ("CHV PF"). CHV I GP LLC (formerly known as "CHV III GP LLC") is the general partner of CHV Investments LLC ("CHV Investments") and Catalyst Health Ventures Follow-on Fund, L.P. ("CHV FO", together with CHV LP, CHV PF and CHV Investments, the "CHV Funds"). Joshua Phillips, a member of the Issuer's board of directors, is a managing member of CHV GP LLC and CHV I GP LLC, and a limited partner of CHV PF, CHV Investments, CHV GP LLC, and CHV I GP LLC. The securities held by the CHV Funds may be deemed to be beneficially owned by Joshua Phillips. Joshua Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
Phillips JoshuaDirector
|
OtherClass A Common Stock | 381,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000119 · wk-form4_1717634111.xml · nonDerivative · entry 1 Phillips Joshua · CIK 0001871555 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Catalyst Health Ventures, L.P. Disclosed balance after: 6,753 F1 · kind: Catalyst Health Ventures, L.P. ("CHV LP") distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · ownership.nature: CHV GP LLC is the general partner of CHV LP and Catalyst Health Ventures (PF), L.P. ("CHV PF"). CHV I GP LLC (formerly known as "CHV III GP LLC") is the general partner of CHV Investments LLC ("CHV Investments") and Catalyst Health Ventures Follow-on Fund, L.P. ("CHV FO", together with CHV LP, CHV PF and CHV Investments, the "CHV Funds"). Joshua Phillips, a member of the Issuer's board of directors, is a managing member of CHV GP LLC and CHV I GP LLC, and a limited partner of CHV PF, CHV Investments, CHV GP LLC, and CHV I GP LLC. The securities held by the CHV Funds may be deemed to be beneficially owned by Joshua Phillips. Joshua Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
CRITCHFIELD GREGORY CDirector
|
OtherClass A Common Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000120 · wk-form4_1717634121.xml · nonDerivative · entry 2 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,153 F3 · kind: Pro rata distribution from Catalyst Health Ventures (PF) L.P., of which the Reporting Person is a non-managing member. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:35 UTC |
CRITCHFIELD GREGORY CDirector
|
OtherClass A Common Stock | 195 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000120 · wk-form4_1717634121.xml · nonDerivative · entry 1 CRITCHFIELD GREGORY C · CIK 0001191080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,140 F1 · kind: Pro rata distribution from Catalyst Health Ventures, L.P., of which the Reporting Person is a non-managing member. F2 · balance_after: The Reporting Person purchased 5,000 shares of Class A Common Stock pursuant to the Sera Prognostics, Inc. 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of December 1, 2022 to May 31, 2023. Read SEC document |
| May 15, 2024 Filed May 15, 2024 22:23 UTC |
Kearney PaulChief Data Officer
|
SaleClass A Common Stock | 10,387 | $8.24 | $85,588.88 |
DisclosureSEC source: 0001534969-24-000114 · wk-form4_1715811775.xml · nonDerivative · entry 1 Kearney Paul · CIK 0001888075 · Chief Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,300 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.12 to $8.38, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| May 10, 2024 Filed May 14, 2024 23:16 UTC |
Kearney PaulChief Data Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 44,646 | Not disclosed Strike: $0.83 | Not disclosed |
DisclosureSEC source: 0001534969-24-000111 · wk-form4_1715728567.xml · derivative · entry 2 Kearney Paul · CIK 0001888075 · Chief Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 44,646 shares Expires 2024-08-20 F1 · price: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest immediately and were granted in exchange for the Reporting Person's agreement to cancel the stock options represented in Table II of this Form 4. F2 · derivative.exercise_date: The shares subject to this canceled option were fully vested and exercisable. Read SEC document |
| May 10, 2024 Filed May 14, 2024 23:16 UTC |
Kearney PaulChief Data Officer
|
GrantClass A Common Stock | 40,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001534969-24-000111 · wk-form4_1715728567.xml · nonDerivative · entry 1 Kearney Paul · CIK 0001888075 · Chief Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,687 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest immediately and were granted in exchange for the Reporting Person's agreement to cancel the stock options represented in Table II of this Form 4. Read SEC document |
| May 08, 2024 Filed May 10, 2024 21:40 UTC |
Harrison Robert GardnerChief Information Officer
|
SaleClass A Common Stock | 4,902 | $9.59 | $47,010.18 |
DisclosureSEC source: 0001534969-24-000092 · wk-form4_1715377248.xml · nonDerivative · entry 1 Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,795 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| May 08, 2024 Filed May 10, 2024 21:42 UTC |
Kearney PaulChief Data Officer
|
SaleClass A Common Stock | 4,205 | $9.59 | $40,325.95 |
DisclosureSEC source: 0001534969-24-000097 · wk-form4_1715377313.xml · nonDerivative · entry 1 Kearney Paul · CIK 0001888075 · Chief Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,833 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| May 08, 2024 Filed May 10, 2024 21:41 UTC |
Boniface John J.Chief Scientific Officer
|
SaleClass A Common Stock | 4,902 | $9.59 | $47,010.18 |
DisclosureSEC source: 0001534969-24-000096 · wk-form4_1715377301.xml · nonDerivative · entry 1 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,869 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| May 08, 2024 Filed May 10, 2024 21:41 UTC |
Aerts AustinChief Financial Officer
|
SaleClass A Common Stock | 6,592 | $9.59 | $63,217.28 |
DisclosureSEC source: 0001534969-24-000094 · wk-form4_1715377273.xml · nonDerivative · entry 1 Aerts Austin · CIK 0001979974 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,896 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| May 08, 2024 Filed May 10, 2024 21:41 UTC |
Jackson BenjaminGeneral Counsel
|
SaleClass A Common Stock | 4,902 | $9.59 | $47,010.18 |
DisclosureSEC source: 0001534969-24-000095 · wk-form4_1715377287.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001779964 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,277 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| May 08, 2024 Filed May 10, 2024 21:41 UTC |
Lindgardt ZhenyaDirector · Chief Executive Officer
|
SaleClass A Common Stock | 11,992 | $9.59 | $115,003.28 |
DisclosureSEC source: 0001534969-24-000093 · wk-form4_1715377260.xml · nonDerivative · entry 1 Lindgardt Zhenya · CIK 0001891299 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 896,112 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $9.14 to $10.55, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 21:56 UTC |
Boniface John J.Chief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 24,474 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · derivative · entry 7 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 24,474 shares Expires 2024-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 21:56 UTC |
Boniface John J.Chief Scientific Officer
|
SaleClass A Common Stock | 24,474 | $9.04 | $221,244.96 |
DisclosureSEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 5 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,771 F1 · kind: The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.58 to $9.24, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 28, 2024 Filed Mar 28, 2024 21:56 UTC |
Boniface John J.Chief Scientific Officer
|
Exercise / conversionClass A Common Stock | 24,474 | $0.91 | $22,271.34 |
DisclosureSEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 4 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2024 Filed Mar 28, 2024 21:56 UTC |
Boniface John J.Chief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 48,909 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · derivative · entry 6 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,474 Underlying: Class A Common Stock · 48,909 shares Expires 2024-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable. Read SEC document |
| March 27, 2024 Filed Mar 28, 2024 21:56 UTC |
Boniface John J.Chief Scientific Officer
|
SaleClass A Common Stock | 48,909 | $9.62 | $470,504.58 |
DisclosureSEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 3 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,771 F1 · kind: The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.85, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 27, 2024 Filed Mar 28, 2024 21:56 UTC |
Boniface John J.Chief Scientific Officer
|
Exercise / conversionClass A Common Stock | 48,909 | $0.91 | $44,507.19 |
DisclosureSEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 2 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2024 Filed Mar 28, 2024 21:56 UTC |
Boniface John J.Chief Scientific Officer
|
SaleClass A Common Stock | 3,753 | $9.62 | $36,103.86 |
DisclosureSEC source: 0001534969-24-000073 · wk-form4_1711662978.xml · nonDerivative · entry 1 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,771 F1 · kind: The transaction(s) reported on this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.85, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 00:00 UTC |
Lindgardt ZhenyaDirector · Chief Executive Officer
|
SaleClass A Common Stock | 38,899 | $9.37 | $364,483.63 |
DisclosureSEC source: 0001534969-24-000065 · wk-form4_1711497606.xml · nonDerivative · entry 1 Lindgardt Zhenya · CIK 0001891299 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 908,104 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.86, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 00:00 UTC |
Aerts AustinChief Financial Officer
|
SaleClass A Common Stock | 8,092 | $9.37 | $75,822.04 |
DisclosureSEC source: 0001534969-24-000064 · wk-form4_1711497592.xml · nonDerivative · entry 1 Aerts Austin · CIK 0001979974 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,488 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.86, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| March 26, 2024 Filed Mar 26, 2024 21:38 UTC |
Boniface John J.Chief Scientific Officer
|
SaleClass A Common Stock | 21,438 | $9.55 | $204,732.90 |
DisclosureSEC source: 0001534969-24-000061 · wk-form4_1711489091.xml · nonDerivative · entry 1 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,524 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.17 to $9.83, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 25, 2024 Filed Mar 26, 2024 20:20 UTC |
Boniface John J.Chief Scientific Officer
|
SaleClass A Common Stock | 22,163 | $9.10 | $201,683.30 |
DisclosureSEC source: 0001534969-24-000059 · wk-form4_1711484417.xml · nonDerivative · entry 1 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,962 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:15 UTC |
Harrison Robert GardnerChief Information Officer
|
SaleClass A Common Stock | 2,138 | $9.02 | $19,284.76 |
DisclosureSEC source: 0001534969-24-000032 · wk-form4_1709846139.xml · nonDerivative · entry 1 Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,697 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:16 UTC |
Boniface John J.Chief Scientific Officer
|
SaleClass A Common Stock | 1,664 | $9.02 | $15,009.28 |
DisclosureSEC source: 0001534969-24-000035 · wk-form4_1709846184.xml · nonDerivative · entry 1 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,125 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:16 UTC |
Aerts AustinChief Financial Officer
|
SaleClass A Common Stock | 444 | $9.02 | $4,004.88 |
DisclosureSEC source: 0001534969-24-000034 · wk-form4_1709846171.xml · nonDerivative · entry 1 Aerts Austin · CIK 0001979974 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,580 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:16 UTC |
Kearney PaulChief Data Officer
|
SaleClass A Common Stock | 1,028 | $9.02 | $9,272.56 |
DisclosureSEC source: 0001534969-24-000033 · wk-form4_1709846158.xml · nonDerivative · entry 1 Kearney Paul · CIK 0001888075 · Chief Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,038 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 21:15 UTC |
Jackson BenjaminGeneral Counsel
|
SaleClass A Common Stock | 1,856 | $9.02 | $16,741.12 |
DisclosureSEC source: 0001534969-24-000031 · wk-form4_1709846125.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001779964 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,179 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.78 to $9.45, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 21:56 UTC |
Harrison Robert GardnerChief Information Officer
|
SaleClass A Common Stock | 5,665 | $8.03 | $45,489.95 |
DisclosureSEC source: 0001534969-24-000009 · wk-form4_1707342992.xml · nonDerivative · entry 1 Harrison Robert Gardner · CIK 0001421563 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,835 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 21:57 UTC |
Jackson BenjaminGeneral Counsel
|
SaleClass A Common Stock | 5,665 | $8.03 | $45,489.95 |
DisclosureSEC source: 0001534969-24-000012 · wk-form4_1707343032.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001779964 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,035 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 21:57 UTC |
Boniface John J.Chief Scientific Officer
|
SaleClass A Common Stock | 5,665 | $8.03 | $45,489.95 |
DisclosureSEC source: 0001534969-24-000011 · wk-form4_1707343015.xml · nonDerivative · entry 1 Boniface John J. · CIK 0001870674 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,789 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 21:56 UTC |
Kearney PaulChief Data Officer
|
SaleClass A Common Stock | 4,984 | $8.03 | $40,021.52 |
DisclosureSEC source: 0001534969-24-000010 · wk-form4_1707343003.xml · nonDerivative · entry 1 Kearney Paul · CIK 0001888075 · Chief Data Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,066 F1 · kind: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $8.00 to $8.11, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.